AbbVie Inc: Diferență între versiuni
Admin (discuție | contribuții) (csv2wiki) |
Admin (discuție | contribuții) Fără descriere a modificării |
||
Linia 1: | Linia 1: | ||
Pagina dedicata companiei AbbVie Inc listata cu simbolul US.ABBV | Pagina dedicata companiei AbbVie Inc listata cu simbolul US.ABBV | ||
Linia 5: | Linia 4: | ||
AbbVie Inc. (AbbVie) (https://www.abbvie.com/) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses. | AbbVie Inc. (AbbVie) (https://www.abbvie.com/) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses. | ||
==Grafic actiuni companie== | |||
<iframe key="tradeville" path="graficSimbol/US.ABBV" /> | |||
==Ultimele stiri despre AbbVie Inc (US.ABBV)== | ==Ultimele stiri despre AbbVie Inc (US.ABBV)== | ||
Linia 13: | Linia 14: | ||
addfirstcategorydate=false | addfirstcategorydate=false | ||
</dynamicpagelist> | </dynamicpagelist> | ||
[[Categorie:US.ABBV]][[Categorie:Stiri despre companii]] | [[Categorie:US.ABBV]][[Categorie:Stiri despre companii]] |
Versiunea curentă din 18 septembrie 2024 15:34
Pagina dedicata companiei AbbVie Inc listata cu simbolul US.ABBV
Descriere companie[edit | ]
AbbVie Inc. (AbbVie) (https://www.abbvie.com/) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.
Grafic actiuni companie[edit | ]
Ultimele stiri despre AbbVie Inc (US.ABBV)[edit | ]
- Cifra de afaceri din comertul cu amanuntul creste - 08 aprilie 2024
- 📰 Joia asta pe pietele internationale
- Tendinte mixte in evolutia activitatii economice pentru T4 - 30 octombrie 2023
- AbbVie's stock is down 3% after missing on revenue in the first quarter of 2022 (US.ABBV) - 29 aprilie 2022
- AbbVie Inc